Demonstration of modified inactive first component of complement (C1) inhibitor in the plasmas of C1 inhibitor-deficient patients
about
Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working GroupHAE therapies: past present and future.Synthesis of C1 inhibitor in fibroblasts from patients with type I and type II hereditary angioneurotic edemaPlasma levels of C1- inhibitor complexes and cleaved C1- inhibitor in patients with hereditary angioneurotic edema.Laparoscopic splenectomy in a patient with acquired angioneurotic edema.Autoimmune angioedema: a new role for autoantibody in disease pathogenesis.Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies: from pathophysiology to the clinic.How we manage persons with hereditary angioedema.HAE Pathophysiology and Underlying Mechanisms.Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema.Proteolytic inactivation of plasma C1- inhibitor in sepsis.Brazilian Guidelines for Hereditary Angioedema Management - 2017 Update Part 1: Definition, Classification and Diagnosis.Nine year follow-up of a rare case of angioedema due to acquired C1-inhibitor deficiency with late onset and good response to attenuated androgenThe Pathophysiology of Hereditary AngioedemaNew promise and hope for treating hereditary angioedema
P2860
Q27009012-EDFA44BF-978B-4690-9703-472548F051BCQ34063768-76376879-0CCF-4A5F-AB21-D3E52FEC5CF0Q34187487-EBDFFBDF-3287-4F57-9342-1F732941E8EAQ34248456-B49BC123-7D17-46E6-A274-B340EADC7EB1Q35039754-3AF69838-E7BD-454C-BC4C-814AEFE396B3Q37805971-7A1CE0C3-761C-4018-BC6F-7B3404CCD21CQ38058560-7E731E75-142A-4B4D-A469-3566155859F2Q38806437-C2845614-51ED-4109-9173-D55ADC5C08C9Q38837708-00778290-F4E4-46AD-B1C9-8D145F735239Q40378825-77D2A4E0-C395-4C45-87C9-7142A398A122Q41076639-643AB364-F911-4572-8622-886907530C35Q55416639-16394E34-2CD7-4CFD-AE7E-71C580F3FABCQ58551957-BC3B3D45-98BB-4ED6-B0B5-15888BC25BABQ58615532-0D1F3FF0-9DBD-4B94-B5B0-DFD693D1FBABQ58615572-13878B2B-D360-4065-A3DB-7F6741401EB9
P2860
Demonstration of modified inactive first component of complement (C1) inhibitor in the plasmas of C1 inhibitor-deficient patients
description
1986 nî lūn-bûn
@nan
1986 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
Demonstration of modified inac ...... 1 inhibitor-deficient patients
@ast
Demonstration of modified inac ...... 1 inhibitor-deficient patients
@en
Demonstration of modified inactive first component of complement
@nl
type
label
Demonstration of modified inac ...... 1 inhibitor-deficient patients
@ast
Demonstration of modified inac ...... 1 inhibitor-deficient patients
@en
Demonstration of modified inactive first component of complement
@nl
prefLabel
Demonstration of modified inac ...... 1 inhibitor-deficient patients
@ast
Demonstration of modified inac ...... 1 inhibitor-deficient patients
@en
Demonstration of modified inactive first component of complement
@nl
P2860
P356
P1476
Demonstration of modified inac ...... 1 inhibitor-deficient patients
@en
P2093
P2860
P304
P356
10.1172/JCI112610
P407
P577
1986-08-01T00:00:00Z